q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

March 2022 Medicare Drug List Updates: Fifty-two (52) medications added to 2022 Medicare Part D Drug plan formularies.

Category: Monthly Formulary Changes
Published: Mar, 29 2022 02:03:28
< Previous
Next >
The recently released March 2022 Medicare Part D prescription drug plan formulary (drug lists) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The March formulary updates include the addition of 52 new National Drug Codes (NDCs), representing 37 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the March 2022 Formulary update include twelve (12) newly-added brand-name drugs

The March drug data updates include twenty-two (22) new brand-name drugs, twelve (12) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • BESREMI®,
  • CENTANY®,
  • EPRONTIA®,
  • EXKIVITY®,
  • LIVMARLI®,
  • LIVTENCITY®,
  • OPZELURA®,
  • QULIPTA®,
  • SCEMBLIX®,
  • TICOVAC®,
  • TRUDHESA®, and
  • VUITY®.

The March 2022 Formulary update includes three (3) newly-added generic drugs

The March Medicare Part D drug data also includes fifteen (15) new generic medications, three (3) of which are newly-introduced generic drugs.  These new generic drugs include:
  • CLORAZEPATE [TRANXENE T-TAB®],
  • CLORAZEPATE [TRANXENE®], and
  • ROSUVASTATIN-EZETIMIBE [ROSZET®].

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.


Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155


Summary of March 2022 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 52 new March 2022 NDCs is as follows:

Reason for NDC Addition Occurrences
New Drug15
New Drug and Strength20
New Manufacturer and Delivery Form2
New Manufacturer and Strength4
New Manufacturer, Strength and Delivery Form1
New Strength10
Grand Total52

The following chart details the 52 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
00071311223ACCURETIC 10-12.5 MG TABLET23New Strength
00071521223ACCURETIC 20-12.5 MG TABLET23New Strength
51672138409ADAPALENE-BNZYL PEROX 0.3-2.5% GEL W/PUMP [Epiduo]112New Strength
73536050001BESREMI 500 MCG/ML SYRINGE57376New Drug
43538030030CENTANY 2% OINTMENT04New Drug
13107032001CLORAZEPATE 7.5 MG TABLET [Tranxene T-Tab]63402New Drug and Strength
13107032101CLORAZEPATE 15 MG TABLET [Tranxene]63403New Drug and Strength
13107031901CLORAZEPATE 3.75 MG TABLET [Tranxene]63402New Drug and Strength
50222026006DOVONEX 0.005% CREAM (G)22New Drug
63304061501DOXYCYCLINE MONO 75 MG CAPSULE [Okebo]1274New Drug
00024591102DUPIXENT 100 MG/0.67 ML SYRINGE38272New Strength
61958220501EPCLUSA 150-37.5 MG PELLET PACK36223New Manufacturer and Delivery Form
61958220401EPCLUSA 200-50 MG PELLET PACK36223New Manufacturer and Delivery Form
52652900101EPRONTIA 25 MG/ML SOLUTION38348New Drug
67877072131EVEROLIMUS 1 MG TABLET [Zortress]62402New Manufacturer and Strength
63020004012EXKIVITY 40 MG CAPSULE63403New Drug
16729056101HYDROXYCHLOROQUINE 100 MG TABLET13147New Drug and Strength
16729056201HYDROXYCHLOROQUINE 300 MG TABLET13104New Drug and Strength
16729056301HYDROXYCHLOROQUINE 400 MG TABLET13104New Drug and Strength
61269060510KLONOPIN 0.5 MG TABLET01New Manufacturer and Strength
61269062010KLONOPIN 2 MG TABLET01New Manufacturer and Strength
62559030690LIPOFEN 150 MG CAPSULE139New Drug
79378011001LIVMARLI 9.5 MG/ML ORAL SOLUTION665New Drug
64764080056LIVTENCITY 200 MG TABLET766New Drug
13107008499LORAZEPAM 1 MG TABLET [Ativan]63403New Manufacturer and Strength
51862064801MICROGESTIN 24 FE 1 MG-20 MCG TABLET [Tarina Fe 1/20]37216New Strength
00781717612NALOXONE HCL 4 MG NASAL SPRAY [Narcan]51359New Manufacturer, Strength and Delivery Form
54436032530NOCDURNA 27.7 MCG TABLET SL TABLET RAPDIS037New Drug and Strength
54436035030NOCDURNA 55.3 MCG TABLET SL TABLET RAPDIS037New Drug and Strength
65862089888NYLIA 1-35 28 TABLET [Pirmella]55352New Strength
50881000705OPZELURA 1.5% CREAM (G)125New Drug
72786011103OXBRYTA 300 MG TABLET FOR SUSP8111New Strength
72887068203OXYCODONE-ACETAMINOPHEN 7.5-300 TABLET [Prolate]29New Strength
60505437803PAXIL CR 25 MG TABLET ER 24H01New Strength
43598063401PENICILLAMINE 250 MG CAPSULE [Cuprimine]489New Drug
66993084435PREDNISOLONE ODT 10 MG TABLET RAPDIS [Orapred ODT]4110New Drug and Strength
66993084535PREDNISOLONE ODT 15 MG TABLET RAPDIS [Orapred ODT]4112New Drug and Strength
66993084635PREDNISOLONE ODT 30 MG TABLET RAPDIS [Orapred ODT]4110New Drug and Strength
00074709530QULIPTA 10 MG TABLET08New Drug and Strength
00074709630QULIPTA 30 MG TABLET08New Drug and Strength
00074709430QULIPTA 60 MG TABLET08New Drug and Strength
82120012630ROSUVASTATIN-EZETIMIBE 10-10MG TABLET [ROSZET]012New Drug and Strength
82120012730ROSUVASTATIN-EZETIMIBE 20-10MG TABLET [ROSZET]012New Drug and Strength
82120012830ROSUVASTATIN-EZETIMIBE 40-10MG TABLET [ROSZET]012New Drug and Strength
82120012530ROSUVASTATIN-EZETIMIBE 5-10 MG TABLET [ROSZET]012New Drug and Strength
00078109120SCEMBLIX 20 MG TABLET63403New Drug and Strength
00078109820SCEMBLIX 40 MG TABLET63403New Drug and Strength
43538092060SYNALAR 0.01% SOLUTION01New Drug
00069041102TICOVAC 2.4 MCG/0.5 ML SYRINGE54314New Drug
60505265901TRAZODONE 300 MG TABLET [Desyrel]48260New Strength
77530072504TRUDHESA NASAL SPRAY/PUMP221New Drug
00074709804VUITY 1.25% EYE DROPS04New Drug




Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.